[1]
J. M. Baena Cañada, “Trends in Adjuvant Chemotherapy Use in Endocrine-Sensitive, HER-2 Negative Breast Cancer, With 1 to 3 Positive Nodes: A Single-Centre Study”, Arch Breast Cancer, pp. 233–242, Jul. 2021.